Health Care: Drugs

Hemispherx Biopharma Inc (HEB: AMEX)

$0.283 -0.016 | -5.35%
10/24/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 0.30
52 Week High 0.55
52 Week Low 0.19
Avg. Daily Vol. (Mil) 1.78
Beta (3 year) 0.64
Share Related Items
Mkt Cap (Mil) 58.42
Shares Out (Mil) 190.00
Float (Mil) 192.20
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.90
Current Ratio 4.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 308.75
Price/Book 1.93
Price/Cash Flow -3.50
Per Share Data
Earnings -0.10
Sales 0.00
Book Value 0.15
Cash Flow -0.08
Business Summary
Hemispherx Biopharma, Inc. is a specialty pharmaceutical company. It is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
General Information
1617 JFK Boulevard
Philadelphia, PA 19103
www.hemispherx.net
Industry : Drugs
Sector: Health Care
Employees: 39
CEO: William A. Carter,M.D.
Short Interest
Current Month (Mil) 3.20
Previous Month (Mil) 3.24
Short Interest Ratio (Days) 1.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -51.00
Return on Investments -58.30
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with HEB

Latest HEB Headlines from TheStreet

More Financial News for HEB

Press Releases for HEB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter